- CA$5.68bn
- CA$10.03bn
- CA$21.83bn
- 81
- 95
- 50
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19,131 | 5,833 | 6,400 | 16,556 | 21,833 |
Cost of Revenue | |||||
Gross Profit | 11,437 | 2,508 | 2,873 | 8,590 | 13,145 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17,475 | 9,609 | 9,551 | 16,757 | 19,564 |
Operating Profit | 1,656 | -3,776 | -3,151 | -201 | 2,269 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,775 | -4,853 | -3,981 | -1,524 | 2,212 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,476 | -4,647 | -3,602 | -1,700 | 2,276 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,476 | -4,647 | -3,602 | -1,700 | 2,276 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,476 | -4,647 | -3,602 | -1,700 | 2,243 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.37 | -16.8 | -10.1 | -4.72 | 5.98 |